申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US20150152113A1
公开(公告)日:2015-06-04
The disclosure generally relates to compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds modulate the mGluR2 receptor and may be useful for the treatment of various disorders of the central nervous system. Formula (I):
该披露通常涉及I式化合物,包括它们的盐,以及使用这些化合物的组合物和方法。这些化合物可以调节mGluR2受体,可能有助于治疗中枢神经系统的各种疾病。 I式: